You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for New Drug Application (NDA): 204426


✉ Email this page to a colleague

« Back to Dashboard


NDA 204426 describes TAYTULLA, which is a drug marketed by Apil and is included in one NDA. It is available from one supplier. Additional details are available on the TAYTULLA profile page.

The generic ingredient in TAYTULLA is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 204426
Tradename:TAYTULLA
Applicant:Apil
Ingredient:ethinyl estradiol; norethindrone acetate
Patents:0
Suppliers and Packaging for NDA: 204426
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TAYTULLA ethinyl estradiol; norethindrone acetate CAPSULE;ORAL 204426 NDA Allergan, Inc. 0023-5862 0023-5862-29 1 BLISTER PACK in 1 CARTON (0023-5862-29) / 1 KIT in 1 BLISTER PACK
TAYTULLA ethinyl estradiol; norethindrone acetate CAPSULE;ORAL 204426 NDA Allergan, Inc. 0023-5862 0023-5862-30 5 CARTON in 1 TRAY (0023-5862-30) / 1 BLISTER PACK in 1 CARTON (0023-5862-28) / 1 KIT in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.02MG;1MG
Approval Date:Apr 19, 2013TE:ABRLD:Yes

Expired US Patents for NDA 204426

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apil TAYTULLA ethinyl estradiol; norethindrone acetate CAPSULE;ORAL 204426-001 Apr 19, 2013 ⤷  Subscribe ⤷  Subscribe
Apil TAYTULLA ethinyl estradiol; norethindrone acetate CAPSULE;ORAL 204426-001 Apr 19, 2013 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.